The GPIHBP1 gene helps place a fat-clearing enzyme called lipoprotein lipase on the lining of tiny blood vessels. This gene plays an important role in clearing fats from the bloodstream after meals. If you carry a harmful variant in the GPIHBP1 gene, fat may build up in the blood, causing very high triglycerides and sometimes pancreatitis (inflammation of the pancreas), belly pain, or skin bumps called xanthomas. This is a rare inherited cause of chylomicronemia, a condition in which fatty particles stay in the blood longer than they should.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly control when certain processes take place, where they occur, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this topic more deeply, visit the LearnHub.
Overview
GPIHBP1Gene function
What if the gene works
The GPIHBP1 gene helps move a fat clearing enzyme to the inside surface of tiny blood vessels. This supports the breakdown of blood fats, especially after meals, so fats can be used or stored normally.
Risk
What if the gene does not work
When the GPIHBP1 gene does not work properly, fat particles can build up in the blood, causing high triglycerides and chylomicronemia, often from childhood. Milder to more severe variants can affect when problems start and pancreatitis risk.
Treatment
What does that mean for your treatment
Pathogenic variants in the GPIHBP1 gene are managed like familial chylomicronemia syndrome, with a very low fat diet as the main treatment. Standard triglyceride lowering drugs, including fibrates and fish oil, often have limited benefit. In some settings, APOC3 lowering medicines such as volanesorsen or olezarsen can help lower triglyceride levels.
Conditions associated with GPIHBP1
Gene function
What if the gene works
Your body uses the GPIHBP1 gene to handle fats that travel in the blood after a meal. Its protein sits on the lining of very small blood vessels and helps move a key fat breaking enzyme into the right place. Understanding GPIHBP1 gene function helps explain how muscles and fat tissue receive fuel from circulating fats.
The GPIHBP1 gene helps shuttle lipoprotein lipase, an enzyme that breaks down blood fats, across the cells lining tiny blood vessels. This places the enzyme on the blood-facing surface, where circulating fat particles can reach it.
Its protein holds lipoprotein lipase in place on the inner surface of capillaries, the smallest blood vessels. This steady positioning helps the enzyme keep working as blood carries fat-rich particles past.
GPIHBP1 can also bind triglyceride-rich lipoproteins, the particles that carry much of the fat from food through the blood. Bringing these particles close to lipoprotein lipase helps your body release fatty acids for energy or storage.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GPIHBP1 gene can change the protein’s shape, stop it reaching the surface of cells lining blood vessels, or weaken its hold on lipoprotein lipase (the enzyme that breaks down blood fats). This is how GPIHBP1 gene variants affect triglyceride breakdown. Milder variants may leave some activity, while more severe variants can cause major loss of transport and binding. With stronger loss of function, very high triglyceride levels often appear earlier.
How variants are linked to conditions
Pathogenic variants affecting both copies of the GPIHBP1 gene cause familial chylomicronemia syndrome, a rare inherited cause of very high triglycerides. People with this GPIHBP1 gene change may have abdominal pain, repeated pancreatitis, and skin findings such as eruptive xanthomas. Clinicians may also describe this as type I hyperlipoproteinemia.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with disease-causing changes in GPIHBP1, the main risk is set by the gene change itself, but very high blood fat levels and pancreatitis can be made worse by alcohol, a high-fat diet, uncontrolled diabetes, pregnancy, and some medicines such as estrogen. Early monitoring and avoiding known triggers can help lower the chance of complications.
Inheritance of GPIHBP1 variants
Variants in the GPIHBP1 gene linked to GPIHBP1-related chylomicronemia are inherited in an autosomal recessive pattern. This GPIHBP1 inheritance pattern means a person usually develops the condition only when they inherit one nonworking copy from each parent. Parents who each carry one variant are often unaffected, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two working copies. Sons and daughters are affected equally.
What does my GPIHBP1 result mean for my family?
For GPIHBP1, family implications usually fit a recessive pattern linked to very high triglycerides. Brothers and sisters of someone with a disease-causing result may also be affected or may carry the same gene change without having symptoms. Parents are often healthy carriers, and other close relatives may also be carriers, so the result can matter beyond one person in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for GPIHBP1 variants uses a blood or saliva sample, and a laboratory reads the GPIHBP1 gene to look for DNA changes linked to very high triglyceride levels. GPIHBP1 genetic testing for inherited chylomicronemia can confirm whether a pathogenic variant is present and may also help clarify family testing.
When should I consider getting a genetic test?
Consider testing the GPIHBP1 gene if you or your child have extremely high triglycerides, repeated pancreatitis, or a strong family history of severe blood fat problems starting early in life. A result can help confirm a rare inherited problem with clearing fat from the blood and guide family testing.
A genetic result is only one part of your health story
A genetic result can offer useful insight, but how much it reveals depends on the condition and the type of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a treatment, so the same medicine may work better for one person and less well for another. These differences are common and can influence both how effective a treatment feels and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way someone responds to a medication. It studies gene drug patterns to help explain why the same treatment may work differently in different people. With many medicines, genes can influence both how powerfully a drug works and how the body handles it. This information can support treatment choices that are more informed and more individualized. To look into this subject more deeply, you can learn more in the LearnHub.
Drugs influenced by the GPIHBP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about symptoms, side effects, or treatment choices are best discussed with your doctor or pharmacist.
History
The GPIHBP1 gene entered the medical literature in the 2000s during research on rare, very high triglyceride levels and unexplained chylomicronemia. Scientists studying mice first recognized that loss of this gene caused striking fat buildup in the blood, which made it a major clue in lipid research. From these first observations, research expanded steadily. Soon afterward, researchers identified GPIHBP1 variants in people with familial chylomicronemia, linking the gene to a long-standing clinical mystery. That discovery helped reshape understanding of how severe triglyceride disorders can arise. In the years since, GPIHBP1 has become an established part of the history of inherited lipid conditions and modern genetic testing for them.